Gabi Tarcic - 18 Mar 2026 Form 3 Insider Report for Evogene Ltd. (EVGN)

Role
Chief Development Officer
Signature
/s/ Nitsan Deutsch, attorney-in-fact
Issuer symbol
EVGN
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:20:08 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tarcic Gabi Chief Development Officer 6 HASHIKMA ST., MEVASERET ZION, ISRAEL /s/ Nitsan Deutsch, attorney-in-fact 18 Mar 2026 0002085020

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EVGN Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 40,000 $2.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options reported in this row vest over a period of four years, with 25% vesting upon the first anniversary of the November 20, 2024 grant date, and the remainder vesting on an equal quarterly basis (6.25% per quarter) over the following twelve quarters, such that all options will be fully vested on the four-year anniversary of the November 20, 2024 grant date.

Remarks:

Exhibit 24.1 - Power of Attorney.